4
Changes in Ownership
Milestone Pharmaceuticals Inc. Filed Acc 0001787700-26-000002
CFO & EVP of Corp. Development sold 70,252 shares at an average $2.25 ($158,209)
- CFO & EVP of Corp. Development acquired 100,000 shares (grant or award)
- CFO & EVP of Corp. Development acquired 20,100 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hasija Amit CFO & EVP of Corp. Development | 2025-12-12 | Grant or award | +100,000 | 150,000 | D | ||
| Hasija Amit CFO & EVP of Corp. Development | 2025-12-15 | Sale | −58,007 | $2.32 | $134,576 | 91,993 | D |
| Hasija Amit CFO & EVP of Corp. Development | 2026-01-26 | Option exercise | +20,100 | 112,093 | D | ||
| Hasija Amit CFO & EVP of Corp. Development | 2026-01-26 | Sale | −12,245 | $1.93 | $23,633 | 99,848 | D |
| Derivatives | |||||||
| Hasija Amit CFO & EVP of Corp. Development | 2025-12-12 | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | D | ||
| Hasija Amit CFO & EVP of Corp. Development | 2026-01-26 | Option exercise · Restricted Stock Units | −20,100 | 60,300 | D | ||
| Open-market sales · 70,252 sh · avg $2.25 · $158,209 | |||||||
Loading xslF345X05/form4-01282026_060103.xml…